Tympanogen Company
This project seeks to improve the process of antibiotic release from a novel patch that can treat military combat wounds and reduce the occurrence and severity of sepsis, or systemic inflammation. This novel patch contains a hydrogel with inherent antimicrobial properties that can promote healing of a wound while acting as a scaffold for regenerating tissue. Reduced fluid motion in microgravity will allow for more precise studies of this hydrogel behavior and its controlled release from the patch.
Industry:
Risk Mitigation
Headquarters:
USA
Founded Date:
2014
Total Funding:
n/a
Register and Claim Ownership